| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |